Publication: 4200

Publication: 4200

AMBASSADOR Alliance A031501: Phase III Randomized Adjuvant Study of Pembrolizumab in Muscle-Invasive and Locally Advanced Urothelial Carcinoma (MIBC) vs Observation

URL

Google Scholar

Citation:: J Clin Oncol vol 42 (suppl 4) LBA531

Meeting Instance:: ASCO GU 2024
Year:: 2024
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Merck
Grants:: U10CA180821, U10CA180882;U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);

Corr. Author:
Authors:: Andrea B. Apolo Karla V. Ballman Guru Sonpavde Stephanie Berg William Y. Kim Rahul Parikh Min Yuen Teo Randy F. Sweis Daniel Geynisman Petros Grivas Gurkamal Chatta Zachery Roger Reichert Joseph Woong Kim Mehmet Asim Bilen Yujia Wen Olwen Hahn Susan Halabi Gabriela Perez Burbano Michael J. Morris Jonathan E. Rosenberg

Networks:: FL086, KANSAS, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-NC007, LAPS-NY016, LAPS-NY158, MD001

Study: Alliance-A031501
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: